CD8A and infection: Informed by the protective immunity observed after natural infection, vaccine approaches that elicit antiviral SARS-CoV-2-specific CD4+ and CD8+ T cells in coordination with neutralizing antibodies generate more robust and durable protective immunity [23, 38].